ATE400269T1 - Ophtalmische zubereitung enthaltend ein histidin derivat zur behandlung des gereizten auges - Google Patents
Ophtalmische zubereitung enthaltend ein histidin derivat zur behandlung des gereizten augesInfo
- Publication number
- ATE400269T1 ATE400269T1 AT02026095T AT02026095T ATE400269T1 AT E400269 T1 ATE400269 T1 AT E400269T1 AT 02026095 T AT02026095 T AT 02026095T AT 02026095 T AT02026095 T AT 02026095T AT E400269 T1 ATE400269 T1 AT E400269T1
- Authority
- AT
- Austria
- Prior art keywords
- ophtalmic
- treatment
- preparation containing
- histidine derivative
- irritated eye
- Prior art date
Links
- 150000002410 histidine derivatives Chemical class 0.000 title abstract 2
- 239000012736 aqueous medium Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Eyeglasses (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001366647A JP2003171276A (ja) | 2001-11-30 | 2001-11-30 | 眼精疲労改善眼科用組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE400269T1 true ATE400269T1 (de) | 2008-07-15 |
Family
ID=19176513
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02026095T ATE400269T1 (de) | 2001-11-30 | 2002-11-22 | Ophtalmische zubereitung enthaltend ein histidin derivat zur behandlung des gereizten auges |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1316310B1 (de) |
| JP (1) | JP2003171276A (de) |
| AT (1) | ATE400269T1 (de) |
| DE (1) | DE60227476D1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7795203B2 (en) * | 2002-09-30 | 2010-09-14 | Babizhayev Mark A | Method for topical treatment of eye disease and composition and device for said treatment |
| US20040137068A1 (en) * | 2002-12-20 | 2004-07-15 | Rajiv Bhushan | Ophthalmic formulation for the prevention and treatment of adverse ocular conditions, particularly those associated with the aging eye |
| FR2863496A1 (fr) * | 2003-12-12 | 2005-06-17 | Anben Pharma | Composition therapeutique destinee au traitement des troubles de l'accomodation de l'oeil humain |
| CN100345594C (zh) * | 2004-01-19 | 2007-10-31 | 无锡杰西医药科技有限公司 | 乙酰唑胺滴眼液 |
| US20070148099A1 (en) * | 2005-12-27 | 2007-06-28 | Burke Susan E | Use of aroma compounds as defoaming agents for ophthalmic solutions with high concentrations of surfactants |
| JP2009084235A (ja) * | 2007-10-02 | 2009-04-23 | Lion Corp | 眼科用抗充血剤及び抗充血用眼科組成物 |
| US20090264375A1 (en) * | 2007-12-21 | 2009-10-22 | Alcon Research, Ltd. | Intraocular irrigating solutions and methods for treating corneal edema |
| WO2010010689A1 (ja) * | 2008-07-22 | 2010-01-28 | 株式会社メニコン | コンタクトレンズ用液剤 |
| NL2002214C2 (en) * | 2008-11-17 | 2010-05-18 | Louis Johan Wagenaar | Contact lens care solution. |
| WO2012005311A1 (ja) * | 2010-07-06 | 2012-01-12 | ロート製薬株式会社 | コンタクトレンズケア用組成物 |
| WO2012066655A1 (ja) * | 2010-11-17 | 2012-05-24 | 株式会社メニコン | ソフトコンタクトレンズ装着方法、コンタクトレンズ用液及びソフトコンタクトレンズパッケージ |
| JP6304475B2 (ja) * | 2013-01-31 | 2018-04-04 | ロート製薬株式会社 | 点眼剤 |
| JP6223890B2 (ja) * | 2014-03-31 | 2017-11-01 | 株式会社メニコン | 眼科用組成液及びその使用方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0687887A (ja) * | 1992-08-19 | 1994-03-29 | Upjohn Co:The | ペプチドのエナミン誘導体およびそれをプロドラッグとして含有するペプチド製剤 |
| FR2701948B1 (fr) * | 1993-02-22 | 1996-07-26 | Exsymol Sa | Produit de couplage de l'histamine ou l'histamine méthyl-substituée et d'un acide aminé, procédé de préparation et applications thérapeutiques, cosmétologiques et agroalimentaires. |
| FR2701947B1 (fr) * | 1993-02-22 | 1995-05-05 | Exsymol Sa | Produit de couplage de l'histamine et d'un acide aminé, procédé de préparation, et applications thérapeutiques et cosmétologiques. |
| GB0017028D0 (en) * | 2000-07-11 | 2000-08-30 | Ks Biomedix Ltd | Peptides and their therapeutic use |
-
2001
- 2001-11-30 JP JP2001366647A patent/JP2003171276A/ja active Pending
-
2002
- 2002-11-22 EP EP02026095A patent/EP1316310B1/de not_active Expired - Lifetime
- 2002-11-22 AT AT02026095T patent/ATE400269T1/de not_active IP Right Cessation
- 2002-11-22 DE DE60227476T patent/DE60227476D1/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE60227476D1 (de) | 2008-08-21 |
| JP2003171276A (ja) | 2003-06-17 |
| EP1316310B1 (de) | 2008-07-09 |
| EP1316310A1 (de) | 2003-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE400269T1 (de) | Ophtalmische zubereitung enthaltend ein histidin derivat zur behandlung des gereizten auges | |
| ATE254461T1 (de) | Behandlung von augenschmerzen | |
| DE69907664D1 (de) | Verfahren zur Herstellung von wässrigen Formulierungen für ophthalmische Verwendung | |
| ATE491434T1 (de) | Augentropfen enthaltend ketotifen | |
| ATE375174T1 (de) | Zusammensetzung und verfahren zur pflege von kontaktlinsen | |
| DE69521620D1 (de) | Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom | |
| ATE402712T1 (de) | Synergistische antimikrobielle ophthalmische zubereitungen mit chlorit- und wasserstoffperoxid | |
| MY106166A (en) | Contact lens disinfecting system. | |
| EP1646614A4 (de) | Ophthalmische zusammensetzungen zur behandlung der okularen hypertonie | |
| EP1732484A4 (de) | Ophthalmisches implantat zur behandlung von glaukom | |
| ATE271390T1 (de) | Verwendung von azithromycin zur topischen behandlung von augeninfektionen | |
| DE60219614D1 (de) | 3, 7 thiaprostansäurederivate als mittel zur verminderung des augeninnendruckes | |
| DE60021908D1 (de) | Hydroxyeicosatetraenoatsalze, zusammensetzungen und verfahren zur verwendung zur behandlung des trockenen auges | |
| BR0206362B1 (pt) | Composição para tratamento de lentes de contato contendo dexpantenol, seu uso e método para limpeza e opcionalmente desinfecção de uma lente decontato | |
| DE60335404D1 (de) | Verwendung von 4-aminochinolin-verbindungen zur behandlung entzündlicher erkrankungen des auges | |
| EP1664011A4 (de) | Ophthalmische zusammensetzungen zur behandlung der okularen hypertonie | |
| DE60218153D1 (de) | Verwendung von proteasom-inhibitoren zur behandlung des trockenen auges | |
| EP2062872A3 (de) | Verwendung von Bisaminen zur Verstärkung der antimikrobiellen Wirkung von wässrigen Zusammensetzungen | |
| DE60135972D1 (de) | Orhthalmologische zusammenstellungen zur behandlung von ocularer hypertension | |
| DE50008764D1 (de) | Vorrichtung für eine medizinische behandlung des auges mit laserstrahlung | |
| DE60138371D1 (de) | PROSTAGLANDINE zur Behandlung von Lichtstrahlung erzeugten Augenerkrankungen wie Photoretinitis | |
| ATE330596T1 (de) | Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen | |
| DE69912304D1 (de) | Verwendung von staurosporine derivaten zur behandlung von okularen neovaskularen erkrankungen | |
| TW200500101A (en) | Quaternary ammonium esters for disinfection and preservation | |
| ATE330938T1 (de) | Disulfid-derivate verwendbar zur behandlung von allergischen erkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |